|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 47/34 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 31/436 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Patento numeris | 3565553 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17890478.5 |
| Europos patento paraiškos padavimo data | 2017-12-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-11-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-04-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2017/047408 |
| Data | 2017-12-29 |
| (87) | Numeris | WO 2018/128173 |
| Data | 2018-07-12 |
| (30) | Numeris | Data | Šalis |
| 201762443599 P | 2017-01-06 | US |
| (72) |
KUNDU, Aishwarya , US
ESCUDERO, Cecile , US
MUDUMBA, Sreenivasu , US
|
| (73) |
Santen Pharmaceutical Co., Ltd. ,
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku
Osaka-shi
Osaka 533-8651,
JP
|
| (54) | INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER |
| INTRATUMORAL ADMINISTRATION OF SIROLIMUS FOR TREATMENT OF PROSTATE CANCER |